Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices
  • Policy / Pricing

CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices

FDA

CMS and FDA announce the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a new pathway designed to expedite access to certain FDA-designated Class II and Class III

Policy / PricingRead full story

pharminent April 23, 2026 (Last updated: April 23, 2026)

FDA

CMS and FDA announce the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a new pathway designed to expedite access to certain FDA-designated Class II and Class III

Policy / PricingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
Next: Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change

Related Stories

  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
  • Policy / Pricing

UK partners with Eli Lilly on obesity plan

pharminent June 29, 2026
  • Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.